Activity ratios measure how efficiently a company performs day-to-day tasks, such us the collection of receivables and management of inventory.
Short-term Activity Ratios (Summary)
Turnover Ratios
Average No. Days
Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).
The analysis of operating activity ratios indicates a general stabilization of asset utilization and a significant improvement in liquidity management toward the end of the observed period. Efficiency in managing short-term assets and liabilities has evolved, resulting in a more favorable cash position by the final fiscal year.
- Inventory Management
- Inventory turnover remained relatively stable over the six-year period, fluctuating within a narrow range between 3.38 and 3.78. The average inventory processing period peaked at 108 days in 2017 before returning to 97 days by 2021. This suggests a consistent approach to stock management with a return to peak efficiency levels by the end of the period.
- Receivables Management
- The receivables turnover ratio experienced a slight decline between 2016 and 2018, reaching a low of 6.89, which corresponded with an increase in the average receivable collection period from 47 to 53 days. However, a recovery trend followed, culminating in a peak turnover of 8.11 and a period low of 45 days in 2021, indicating an acceleration in the collection of outstanding invoices.
- Payables Strategy
- A distinct downward trend is observed in the payables turnover ratio, which decreased from 9.76 in 2016 to 6.04 in 2021. This correlates with a steady increase in the average payables payment period, which rose from 37 days to 60 days. This pattern suggests a strategic shift toward extending payment terms with suppliers, thereby retaining cash within the organization for longer durations.
- Operating and Cash Conversion Cycles
- The operating cycle showed moderate volatility, peaking at 161 days in 2017 before declining to 142 days in 2021. More significantly, the cash conversion cycle exhibited a marked improvement, dropping from 114 days in 2017 to 82 days in 2021. This compression of the cash conversion cycle is the result of combined improvements in inventory and receivables turnover, paired with the extended payables payment period.
- Working Capital Efficiency
- Working capital turnover exhibited extreme volatility, characterized by an irregular spike to 81.96 in 2018 and a sharp decline to 0.79 in 2017. This instability suggests significant fluctuations in the net working capital balance relative to revenue, although the ratio stabilized to 9.15 by 2021.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?
Inventory Turnover
| Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | Sep 30, 2016 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||
| Cost of products sold | 10,821) | 9,540) | 9,002) | 8,721) | 6,151) | 6,492) | |
| Inventories | 2,866) | 2,743) | 2,579) | 2,451) | 1,818) | 1,719) | |
| Short-term Activity Ratio | |||||||
| Inventory turnover1 | 3.78 | 3.48 | 3.49 | 3.56 | 3.38 | 3.78 | |
| Benchmarks | |||||||
| Inventory Turnover, Competitors2 | |||||||
| Abbott Laboratories | 3.59 | — | — | — | — | — | |
| Intuitive Surgical Inc. | 2.98 | — | — | — | — | — | |
| Medtronic PLC | 2.43 | — | — | — | — | — | |
| Inventory Turnover, Sector | |||||||
| Health Care Equipment & Services | 31.85 | — | — | — | — | — | |
| Inventory Turnover, Industry | |||||||
| Health Care | 7.90 | — | — | — | — | — | |
Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).
1 2021 Calculation
Inventory turnover = Cost of products sold ÷ Inventories
= 10,821 ÷ 2,866 = 3.78
2 Click competitor name to see calculations.
Operational activity between September 30, 2016, and September 30, 2021, is characterized by a significant expansion in both the scale of production costs and the volume of held inventory, while maintaining a relatively stable efficiency ratio.
- Cost of Products Sold (COPS)
- A strong upward trajectory in the cost of products sold is observed over the six-year period. Following a slight decrease between 2016 and 2017, there was a substantial increase in 2018, where costs rose from 6,151 million USD to 8,721 million USD. This growth trend continued steadily through 2021, reaching a peak of 10,821 million USD, representing a total increase of approximately 66.5% from the 2016 baseline.
- Inventory Asset Levels
- Inventories demonstrated a consistent and uninterrupted increase throughout the analyzed timeframe. The value of inventories rose from 1,719 million USD in 2016 to 2,866 million USD in 2021. The most pronounced growth occurred between 2017 and 2018, mirroring the sharp increase observed in the cost of products sold, suggesting a strategic expansion of stock to support higher sales volumes.
- Inventory Turnover Ratio
- The inventory turnover ratio remained remarkably stable despite the significant growth in absolute dollar values. After an initial decline from 3.78 in 2016 to 3.38 in 2017, the ratio fluctuated within a narrow band between 3.48 and 3.56 for the subsequent three years. By September 30, 2021, the ratio returned to 3.78, matching the 2016 level. This indicates that the company successfully scaled its inventory holdings in direct proportion to its cost of products sold, maintaining a constant rate of inventory liquidation.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?
Receivables Turnover
| Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | Sep 30, 2016 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||
| Revenues | 20,248) | 17,117) | 17,290) | 15,983) | 12,093) | 12,483) | |
| Trade receivables, net | 2,497) | 2,398) | 2,345) | 2,319) | 1,744) | 1,618) | |
| Short-term Activity Ratio | |||||||
| Receivables turnover1 | 8.11 | 7.14 | 7.37 | 6.89 | 6.93 | 7.72 | |
| Benchmarks | |||||||
| Receivables Turnover, Competitors2 | |||||||
| Abbott Laboratories | 6.64 | — | — | — | — | — | |
| Elevance Health Inc. | 20.66 | — | — | — | — | — | |
| Intuitive Surgical Inc. | 7.30 | — | — | — | — | — | |
| Medtronic PLC | 5.51 | — | — | — | — | — | |
| UnitedHealth Group Inc. | 20.07 | — | — | — | — | — | |
| Receivables Turnover, Sector | |||||||
| Health Care Equipment & Services | 14.76 | — | — | — | — | — | |
| Receivables Turnover, Industry | |||||||
| Health Care | 8.00 | — | — | — | — | — | |
Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).
1 2021 Calculation
Receivables turnover = Revenues ÷ Trade receivables, net
= 20,248 ÷ 2,497 = 8.11
2 Click competitor name to see calculations.
Analysis of the six-year period reveals a consistent expansion in revenue and a corresponding increase in net trade receivables. Revenues grew from 12,483 million in 2016 to 20,248 million in 2021, while trade receivables increased from 1,618 million to 2,497 million.
- Turnover Ratio Fluctuations
- The receivables turnover ratio exhibited volatility, starting at 7.72 in 2016 and declining to a period low of 6.89 by 2018. This initial downward trend reflects a slowing of the collection cycle relative to sales growth during the 2017-2018 fiscal years.
- Efficiency Recovery
- After 2018, the turnover ratio stabilized and then improved, climbing to 7.37 in 2019 and reaching a peak of 8.11 by 2021. This peak suggests a substantial optimization in credit management and collection processes, resulting in the most efficient conversion of receivables to cash across the reported timeframe.
- Operational Correlation
- The alignment between the surge in revenues and the rise in net receivables suggests that the growth in trade credit was largely a byproduct of increased sales volume. However, the acceleration of the turnover ratio in the final year indicates that the company successfully decoupled revenue growth from receivables accumulation, improving overall liquidity efficiency.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?
Payables Turnover
| Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | Sep 30, 2016 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||
| Cost of products sold | 10,821) | 9,540) | 9,002) | 8,721) | 6,151) | 6,492) | |
| Accounts payable | 1,793) | 1,355) | 1,092) | 1,106) | 797) | 665) | |
| Short-term Activity Ratio | |||||||
| Payables turnover1 | 6.04 | 7.04 | 8.24 | 7.89 | 7.72 | 9.76 | |
| Benchmarks | |||||||
| Payables Turnover, Competitors2 | |||||||
| Abbott Laboratories | 4.21 | — | — | — | — | — | |
| Elevance Health Inc. | 7.59 | — | — | — | — | — | |
| Intuitive Surgical Inc. | 14.45 | — | — | — | — | — | |
| Medtronic PLC | 4.98 | — | — | — | — | — | |
| UnitedHealth Group Inc. | 7.63 | — | — | — | — | — | |
| Payables Turnover, Sector | |||||||
| Health Care Equipment & Services | 7.18 | — | — | — | — | — | |
| Payables Turnover, Industry | |||||||
| Health Care | 5.84 | — | — | — | — | — | |
Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).
1 2021 Calculation
Payables turnover = Cost of products sold ÷ Accounts payable
= 10,821 ÷ 1,793 = 6.04
2 Click competitor name to see calculations.
The analysis of short-term operating activity reveals a consistent decline in the payables turnover ratio between 2016 and 2021. While the cost of products sold experienced an overall upward trajectory, the growth in accounts payable occurred at a more accelerated pace, leading to a deceleration in the frequency with which supplier obligations are settled.
- Cost of Products Sold Trends
- Expenditures on products sold rose from 6,492 million US$ in 2016 to 10,821 million US$ by 2021. Despite a minor contraction in 2017, the general trajectory indicates significant scaling of operational costs, with a notable increase occurring between 2017 and 2018.
- Accounts Payable Dynamics
- Liabilities to suppliers grew steadily from 665 million US$ in 2016 to 1,793 million US$ in 2021. This represents a nearly threefold increase over the period, indicating a higher volume of outstanding obligations at the close of each fiscal year.
- Payables Turnover Interpretation
- The turnover ratio decreased from 9.76 in 2016 to 6.04 in 2021. This downward trend indicates that the company is taking longer to pay its suppliers. The reduction in turnover, particularly between 2019 and 2021, suggests an extension of the payment cycle, which may stem from improved bargaining power with vendors or a strategic decision to optimize working capital by preserving cash.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?
Working Capital Turnover
| Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | Sep 30, 2016 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||
| Current assets | 8,838) | 8,969) | 6,664) | 7,411) | 18,633) | 6,367) | |
| Less: Current liabilities | 6,626) | 5,836) | 5,655) | 7,216) | 3,342) | 4,400) | |
| Working capital | 2,212) | 3,133) | 1,009) | 195) | 15,291) | 1,967) | |
| Revenues | 20,248) | 17,117) | 17,290) | 15,983) | 12,093) | 12,483) | |
| Short-term Activity Ratio | |||||||
| Working capital turnover1 | 9.15 | 5.46 | 17.14 | 81.96 | 0.79 | 6.35 | |
| Benchmarks | |||||||
| Working Capital Turnover, Competitors2 | |||||||
| Abbott Laboratories | 3.87 | — | — | — | — | — | |
| Elevance Health Inc. | 7.23 | — | — | — | — | — | |
| Intuitive Surgical Inc. | 1.22 | — | — | — | — | — | |
| Medtronic PLC | 2.15 | — | — | — | — | — | |
| UnitedHealth Group Inc. | — | — | — | — | — | — | |
| Working Capital Turnover, Sector | |||||||
| Health Care Equipment & Services | 16.28 | — | — | — | — | — | |
| Working Capital Turnover, Industry | |||||||
| Health Care | 8.57 | — | — | — | — | — | |
Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).
1 2021 Calculation
Working capital turnover = Revenues ÷ Working capital
= 20,248 ÷ 2,212 = 9.15
2 Click competitor name to see calculations.
An analysis of the short-term operating activity reveals a divergence between steady revenue growth and significant volatility in working capital management. While revenues expanded from 12,483 million USD in 2016 to 20,248 million USD in 2021, the working capital base experienced extreme fluctuations that heavily distorted the turnover efficiency metrics.
- Revenue Growth Trends
- A consistent upward trajectory in revenues is observed over the six-year period. Aside from a marginal decline in 2017, revenues grew from approximately 12.5 billion USD to over 20.2 billion USD by 2021, indicating a sustained increase in top-line performance and market scale.
- Working Capital Volatility
- Working capital levels exhibited abnormal variance. A substantial peak occurred in 2017 at 15,291 million USD, which was immediately followed by a sharp contraction to 195 million USD in 2018. From 2019 through 2021, the levels stabilized relative to the 2017 outlier, fluctuating between 1,009 million USD and 3,133 million USD.
- Working Capital Turnover Interpretation
- The turnover ratio shows extreme instability as a direct result of the working capital swings. The ratio dropped to a period low of 0.79 in 2017 due to the surge in working capital. Conversely, the ratio spiked to an anomalous 81.96 in 2018, driven by the minimal working capital base relative to the increased revenue of 15,983 million USD. In the final two years of the period, the ratio moderated, moving from 5.46 in 2020 to 9.15 in 2021, suggesting a return to more conventional operating liquidity levels.
The data suggests that the fluctuations in the working capital turnover ratio are primarily driven by changes in the balance sheet composition of current assets and liabilities rather than shifts in operational revenue efficiency. The convergence toward a ratio between 5.0 and 9.0 in the latter years indicates a stabilization of short-term asset utilization.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?
Average Inventory Processing Period
| Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | Sep 30, 2016 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data | |||||||
| Inventory turnover | 3.78 | 3.48 | 3.49 | 3.56 | 3.38 | 3.78 | |
| Short-term Activity Ratio (no. days) | |||||||
| Average inventory processing period1 | 97 | 105 | 105 | 103 | 108 | 97 | |
| Benchmarks (no. days) | |||||||
| Average Inventory Processing Period, Competitors2 | |||||||
| Abbott Laboratories | 102 | — | — | — | — | — | |
| Intuitive Surgical Inc. | 122 | — | — | — | — | — | |
| Medtronic PLC | 150 | — | — | — | — | — | |
| Average Inventory Processing Period, Sector | |||||||
| Health Care Equipment & Services | 11 | — | — | — | — | — | |
| Average Inventory Processing Period, Industry | |||||||
| Health Care | 46 | — | — | — | — | — | |
Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).
1 2021 Calculation
Average inventory processing period = 365 ÷ Inventory turnover
= 365 ÷ 3.78 = 97
2 Click competitor name to see calculations.
The analysis of short-term operating activity reveals a cyclical pattern in inventory management efficiency between 2016 and 2021. After an initial decline in turnover performance, a period of relative stability was observed, followed by a return to baseline efficiency levels by the end of the analyzed period.
- Inventory Turnover Trends
- The inventory turnover ratio exhibited a downward movement from 3.78 in 2016 to a low of 3.38 in 2017. Following this decline, the ratio remained relatively stagnant, fluctuating within a narrow band between 3.48 and 3.56 from 2018 through 2020. A notable recovery occurred by September 30, 2021, when the ratio returned to 3.78, matching the performance recorded in 2016.
- Average Inventory Processing Period
- The time required to process inventory shifted inversely to the turnover ratio. The processing period expanded from 97 days in 2016 to a peak of 108 days in 2017, indicating an increase in the duration inventory was held before sale. Between 2018 and 2020, the period stabilized, maintaining a consistent range between 103 and 105 days. By September 30, 2021, the processing period contracted back to 97 days, demonstrating an improvement in operational velocity and a restoration of the efficiency levels observed at the start of the analyzed timeframe.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?
Average Receivable Collection Period
| Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | Sep 30, 2016 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data | |||||||
| Receivables turnover | 8.11 | 7.14 | 7.37 | 6.89 | 6.93 | 7.72 | |
| Short-term Activity Ratio (no. days) | |||||||
| Average receivable collection period1 | 45 | 51 | 50 | 53 | 53 | 47 | |
| Benchmarks (no. days) | |||||||
| Average Receivable Collection Period, Competitors2 | |||||||
| Abbott Laboratories | 55 | — | — | — | — | — | |
| Elevance Health Inc. | 18 | — | — | — | — | — | |
| Intuitive Surgical Inc. | 50 | — | — | — | — | — | |
| Medtronic PLC | 66 | — | — | — | — | — | |
| UnitedHealth Group Inc. | 18 | — | — | — | — | — | |
| Average Receivable Collection Period, Sector | |||||||
| Health Care Equipment & Services | 25 | — | — | — | — | — | |
| Average Receivable Collection Period, Industry | |||||||
| Health Care | 46 | — | — | — | — | — | |
Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).
1 2021 Calculation
Average receivable collection period = 365 ÷ Receivables turnover
= 365 ÷ 8.11 = 45
2 Click competitor name to see calculations.
The analysis of receivables management from 2016 to 2021 reveals a fluctuating trend in collection efficiency. While there was a notable increase in the time required to collect receivables between 2017 and 2020, a sharp improvement occurred by the end of the period, resulting in the highest efficiency levels observed in the six-year window.
- Receivables Turnover
- The turnover ratio experienced a decline from 7.72 in 2016 to a low of 6.89 in 2018. Following this dip, the ratio fluctuated slightly, recording 7.37 in 2019 and 7.14 in 2020, before rising to a peak of 8.11 in 2021. This upward trajectory in the final year indicates a more rapid conversion of receivables into cash.
- Average Receivable Collection Period
- The collection period increased from 47 days in 2016 to 53 days in 2017 and 2018, reflecting a slowdown in the recovery of outstanding payments. This period of relative inefficiency continued through 2020, where the period remained at 51 days. A significant improvement was realized in 2021, as the collection period dropped to 45 days, representing the shortest duration for receivables collection across the analyzed timeframe.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?
Operating Cycle
| Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | Sep 30, 2016 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data | |||||||
| Average inventory processing period | 97 | 105 | 105 | 103 | 108 | 97 | |
| Average receivable collection period | 45 | 51 | 50 | 53 | 53 | 47 | |
| Short-term Activity Ratio | |||||||
| Operating cycle1 | 142 | 156 | 155 | 156 | 161 | 144 | |
| Benchmarks | |||||||
| Operating Cycle, Competitors2 | |||||||
| Abbott Laboratories | 157 | — | — | — | — | — | |
| Intuitive Surgical Inc. | 172 | — | — | — | — | — | |
| Medtronic PLC | 216 | — | — | — | — | — | |
| Operating Cycle, Sector | |||||||
| Health Care Equipment & Services | 36 | — | — | — | — | — | |
| Operating Cycle, Industry | |||||||
| Health Care | 92 | — | — | — | — | — | |
Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).
1 2021 Calculation
Operating cycle = Average inventory processing period + Average receivable collection period
= 97 + 45 = 142
2 Click competitor name to see calculations.
The operating cycle exhibited a period of volatility between 2016 and 2021, characterized by an initial expansion in duration followed by a period of stabilization and an eventual contraction. The overall efficiency of the operating activity improved significantly toward the end of the analyzed period, ending at a level lower than the initial 2016 baseline.
- Average Inventory Processing Period
- The time required to process inventory fluctuated throughout the period, starting at 97 days in 2016 and peaking at 108 days in 2017. A period of relative stability followed from 2018 to 2020, with values ranging between 103 and 105 days. By September 30, 2021, the processing period decreased to 97 days, indicating a return to the efficiency levels observed at the start of the analysis.
- Average Receivable Collection Period
- The collection of receivables followed a trend similar to inventory processing. The period increased from 47 days in 2016 to a peak of 53 days in 2017 and 2018. Subsequently, a downward trend was observed, with the period declining to 45 days by 2021, representing the shortest collection duration across the six-year span.
- Operating Cycle
- The total operating cycle reached its maximum duration of 161 days in 2017, resulting from the concurrent peaks in both inventory processing and receivable collection. The cycle then entered a plateau, remaining between 155 and 156 days from 2018 through 2020. A significant improvement in operational efficiency occurred in 2021, as the cycle contracted to 142 days, reflecting a reduction of 19 days from the 2017 peak.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?
Average Payables Payment Period
| Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | Sep 30, 2016 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data | |||||||
| Payables turnover | 6.04 | 7.04 | 8.24 | 7.89 | 7.72 | 9.76 | |
| Short-term Activity Ratio (no. days) | |||||||
| Average payables payment period1 | 60 | 52 | 44 | 46 | 47 | 37 | |
| Benchmarks (no. days) | |||||||
| Average Payables Payment Period, Competitors2 | |||||||
| Abbott Laboratories | 87 | — | — | — | — | — | |
| Elevance Health Inc. | 48 | — | — | — | — | — | |
| Intuitive Surgical Inc. | 25 | — | — | — | — | — | |
| Medtronic PLC | 73 | — | — | — | — | — | |
| UnitedHealth Group Inc. | 48 | — | — | — | — | — | |
| Average Payables Payment Period, Sector | |||||||
| Health Care Equipment & Services | 51 | — | — | — | — | — | |
| Average Payables Payment Period, Industry | |||||||
| Health Care | 63 | — | — | — | — | — | |
Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).
1 2021 Calculation
Average payables payment period = 365 ÷ Payables turnover
= 365 ÷ 6.04 = 60
2 Click competitor name to see calculations.
An analysis of the short-term operating activity ratios between September 30, 2016, and September 30, 2021, reveals a consistent trend toward an extension of the time taken to settle obligations with suppliers. There is a clear inverse correlation between the payables turnover ratio and the average payables payment period over the six-year duration.
- Payables Turnover
- A general downward trajectory is observed in the payables turnover ratio, which decreased from 9.76 in 2016 to 6.04 in 2021. While there was a period of relative stability and slight recovery between 2017 and 2019, where the ratio fluctuated between 7.72 and 8.24, a significant decline occurred in the final two years of the period, reaching its lowest point in 2021.
- Average Payables Payment Period
- The average payables payment period demonstrates a corresponding increase, rising from 37 days in 2016 to 60 days in 2021. A notable jump occurred between 2016 and 2017, increasing by 10 days. Following a brief stabilization period from 2017 to 2019, the payment period extended more rapidly, increasing to 52 days in 2020 and peaking at 60 days in 2021.
- Operational Implications
- The expansion of the payment period by 23 days over the analyzed timeframe indicates a shift in working capital management. The lengthening of the cycle suggests that the company has successfully extended its credit terms with suppliers or has opted to delay payments to preserve cash flow, thereby increasing its current liabilities relative to its cost of goods sold.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?
Cash Conversion Cycle
| Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | Sep 30, 2016 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data | |||||||
| Average inventory processing period | 97 | 105 | 105 | 103 | 108 | 97 | |
| Average receivable collection period | 45 | 51 | 50 | 53 | 53 | 47 | |
| Average payables payment period | 60 | 52 | 44 | 46 | 47 | 37 | |
| Short-term Activity Ratio | |||||||
| Cash conversion cycle1 | 82 | 104 | 111 | 110 | 114 | 107 | |
| Benchmarks | |||||||
| Cash Conversion Cycle, Competitors2 | |||||||
| Abbott Laboratories | 70 | — | — | — | — | — | |
| Intuitive Surgical Inc. | 147 | — | — | — | — | — | |
| Medtronic PLC | 143 | — | — | — | — | — | |
| Cash Conversion Cycle, Sector | |||||||
| Health Care Equipment & Services | -15 | — | — | — | — | — | |
| Cash Conversion Cycle, Industry | |||||||
| Health Care | 29 | — | — | — | — | — | |
Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).
1 2021 Calculation
Cash conversion cycle = Average inventory processing period + Average receivable collection period – Average payables payment period
= 97 + 45 – 60 = 82
2 Click competitor name to see calculations.
The cash conversion cycle exhibited relative stability between 2016 and 2020, fluctuating between 104 and 114 days, before experiencing a significant reduction to 82 days by September 30, 2021. This overall trend indicates a substantial improvement in working capital efficiency toward the end of the observed period.
- Average Inventory Processing Period
- Inventory turnover remained comparatively steady, with a peak of 108 days in 2017 followed by a period of consistency around 105 days. A return to 97 days by 2021 suggests an improvement in the speed at which inventory is processed and sold, aligning with the levels seen at the start of the analysis period.
- Average Receivable Collection Period
- The time required to collect receivables rose from 47 days in 2016 to a plateau of 53 days in 2017 and 2018. A subsequent downward trend is observed, with the period reaching a minimum of 45 days in 2021, indicating more efficient credit collection processes.
- Average Payables Payment Period
- A clear and consistent upward trajectory is observed in the payables payment period, which expanded from 37 days in 2016 to 60 days in 2021. This extension of payment terms suggests a strategic increase in the utilization of supplier financing to support liquidity.
The marked decline in the cash conversion cycle during the final year is the result of three converging factors: a reduction in inventory hold times, a faster collection of receivables, and a significant extension of the payables period. Collectively, these shifts have accelerated the movement of cash through the operating cycle, reducing the company's reliance on external financing for short-term operations.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?